Evidence map›Paper›PMID 39367271›Full record

ArticleInternal and emergency medicine2025

Early treatment for Clostridioides difficile infection: retrospective cohort study.

Genady Drozdinsky, Daniella Vronsky, Alaa Atamna, Haim Ben-Zvi, Jihad Bishara, Noa Eliakim-Raz

Abstract read
PubMed Publisher
In one paragraph

Article in Internal and emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Genady DrozdinskyInternal Medicine E, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel. gndy.dzy@gmail.com.ORCID 0000-0003-2166-3906
Daniella VronskyInternal Medicine E, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel.
Alaa AtamnaSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Haim Ben-ZviSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Jihad BisharaSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Noa Eliakim-RazInternal Medicine E, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionClostridioides difficile (CDI) is a common cause of infectious diarrhea. The current recommendation is to initiate empirical antibiotic treatment for suspected CDI who have an anticipated delay of confirmatory results or fulminant colitis. This is based on limited clinical trials. The study aims to examine the impact of early treatment on mortality and clinical outcomes.

methodsThis retrospective cohort study included adult patients with CDI. Early treatment was defined as the initiation of an anti-Clostridioides medication within the first 24 h following stool sampling. Outcomes were 30 and 90 day mortality, length of hospital stay (LOS), recurrence, and colectomy rate. To address potential bias, propensity score matching followed by logistic regression was performed, P value less than 5% was considered statistically significant.

resultsStudy cohort consisted of 796 patients; clinical characteristics were balanced following matching. There was no difference, in favor of early treatment, between the groups regarding 30 day mortality and 90 day mortality with HR of 0.91 (95% CI 0.56-1.47) and 0.7 (95% CI 0.45-1.08), respectively. No statistically significant difference in recurrence rate, ICU admission or colectomy rate was observed. The LOS was shorter in the early-treatment group with 6 days vs. 8 days.

conclusionEarly treatment for CDI had shortened hospital stay. However, it did not affect clinical outcomes in adult patients.

Indexed as

Anti-Bacterial AgentsClostridioides difficileClostridium InfectionsAdultAgedAged, 80 and overCohort StudiesFemaleHumansLength of StayMaleMiddle AgedRetrospective StudiesTreatment OutcomeAnti-Bacterial AgentsAntibioticsAntibiotic stewardshipClostridioides difficileDiarrhea

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.